Obserwuj
Nicolas VABRET
Tytuł
Cytowane przez
Cytowane przez
Rok
Immunology of COVID-19: current state of the science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ...
Immunity 52 (6), 910-941, 2020
17052020
Sinai Immunology Review Project. Immunology of COVID-19: current state of the science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ...
Immunity 52 (6), 910-941, 2020
2682020
Global cancer transcriptome quantifies repeat element polarization between immunotherapy responsive and T cell suppressive classes
A Solovyov, N Vabret, KS Arora, A Snyder, SA Funt, DF Bajorin, ...
Cell reports 23 (2), 512-521, 2018
942018
Sensing microbial RNA in the cytosol
N Vabret, JM Blander
Frontiers in immunology 4, 468, 2013
602013
Advancing scientific knowledge in times of pandemics
N Vabret, R Samstein, N Fernandez, M Merad, ...
Nature Reviews Immunology 20 (6), 338-338, 2020
542020
SARS-CoV-2: the many pros of targeting PLpro
CB McClain, N Vabret
Signal Transduction and Targeted Therapy 5 (1), 223, 2020
512020
Sequence-specific sensing of nucleic acids
N Vabret, N Bhardwaj, BD Greenbaum
Trends in immunology 38 (1), 53-65, 2017
492017
The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity
N Vabret, M Bailly-Bechet, V Najburg, M Müller-Trutwin, B Verrier, ...
PloS one 7 (4), e33502, 2012
422012
Sinai immunology review project; trainees; faculty. Advancing scientific knowledge in times of pandemics
N Vabret, R Samstein, N Fernandez, M Merad
Nat. Rev. Immunol 20 (338), 10.1038, 2020
352020
Antibody responses to SARS-CoV-2 short-lived
N Vabret
Nature Reviews Immunology 20 (9), 519-519, 2020
332020
Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro
N Vabret, M Bailly-Bechet, A Lepelley, V Najburg, O Schwartz, B Verrier, ...
Journal of virology 88 (8), 4161-4172, 2014
262014
Identification of RNA partners of viral proteins in infected cells
AV Komarova, C Combredet, O Sismeiro, MA Dillies, B Jagla, ...
RNA biology 10 (6), 943-956, 2013
212013
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
N Vabret, V Najburg, A Solovyov, R Gopal, C McClain, P Šulc, S Balan, ...
Iscience 25 (7), 2022
142022
Dark genome, bright ideas: recent approaches to harness transposable elements in immunotherapies
AR Cahn, N Bhardwaj, N Vabret
Cancer Cell 40 (8), 792-797, 2022
132022
Preclinical data from SARS-CoV-2 mRNA vaccine
N Vabret
Nature Reviews Immunology 20 (8), 461-461, 2020
122020
Innate immune system activation by viral RNA: How to predict it?
M Kondili, M Roux, N Vabret, M Bailly-Bechet
Virology 488, 169-178, 2016
112016
Y-RNAs lead an endogenous program of RIG-I agonism mobilized upon RNA virus infection and targeted by HIV
N Vabret, V Najburg, A Solovyov, P Šulc, S Balan, G Beauclair, M Chazal, ...
bioRxiv, 773820, 2019
92019
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
S Brinckmann, K Da Costa, MJ van Gils, D Hallengärd, K Klein, L Madeira, ...
Journal of translational medicine 9, 1-12, 2011
82011
Repeat elements amplify TLR signaling
T O’Donnell, N Vabret
Nature Reviews Immunology 21 (12), 760-760, 2021
72021
Hydroxychloroquine: small effects in mild disease
R Levantovsky, N Vabret
Nature Reviews Immunology 20 (6), 350-350, 2020
72020
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20